Drug trials

FILE - In this Wednesday, Aug. 5, 2020 file photo, senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID-19 vaccine to administer to a volunteer, at a clinic in London. U.K. researchers said Tuesday Oct. 20, 2020, they are preparing to begin a controversial experiment that will infect healthy volunteers with the new coronavirus to study the disease in hopes of speeding up development of a vaccine. (AP Photo/Kirsty Wigglesworth, File)
SKY News
October 20, 2020 - 1:54 pm
LONDON (AP) — Danica Marcos wants to be infected with COVID-19. While other people are wearing masks and staying home to avoid the disease, the 22-year-old Londoner has volunteered to contract the new coronavirus as part of a controversial study that hopes to speed development of a vaccine. Marcos...
Read More
FILE - This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020. (Cheryl Gerber/Courtesy of Johnson & Johnson via AP, File)
SKY News
October 12, 2020 - 10:27 pm
NEW BRUNSWICK, N.J. (AP) — A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and...
Read More
People wearing face masks to protect against the new coronavirus look at the movable penguin figures on display inside a mall in Beijing, Monday, July 20, 2020. China's latest coronavirus outbreak has spread to a second city in the northwestern region of Xinjiang. (AP Photo/Andy Wong)
July 20, 2020 - 12:40 pm
WASHINGTON — The White House is reviving its public coronavirus task force briefings, and President Donald Trump will again take on a starring role. Trump says he’ll lead a briefing at 5 p.m. Tuesday, his first since April 27. The coronavirus task force, led by Vice President Mike Pence, briefed...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
SKY News
May 19, 2020 - 8:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More
In this screen grab from video issued by Britain's Oxford University, a volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine, led by Oxford University in England on April 25, 2020. About 100 research groups around the world are pursuing vaccines against the coronavirus, with nearly a dozen in early stages of human trials or poised to start. (University of Oxford via AP)
SKY News
May 04, 2020 - 1:14 am
WASHINGTON (AP) — Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated. About 100 research groups are...
Read More
Vice President Mike Pence speaks to the media in the press briefing room at the White House on March 15, 2020 in Washington, DC. The United States has surpassed 3,000 confirmed cases of the coronavirus.
Getty Images
SKY News
March 15, 2020 - 9:04 pm
WASHINGTON (AP) — The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official. The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente...
Read More
August 02, 2019 - 8:08 am
KAMPALA, Uganda (AP) — Researchers in Uganda are launching the largest-ever trial of an experimental Ebola vaccine that is expected to be deployed in neighboring Congo, where a deadly outbreak has killed over 1,800 people. The trial of the Janssen Pharmaceuticals vaccine involves up to 800 people...
Read More
November 28, 2018 - 6:03 pm
Australian Army veteran Wolfgang Neszpor was stunned when he heard his recently repaired shoulder squeak. "You could really hear it," he said. He recalled when the surgeon examined him and lifted up his arm, "It was a stupid amount of pain." Two months earlier, Neszpor, 36, had gotten a new...
Read More
November 26, 2018 - 7:23 am
DAKAR, Senegal (AP) — Congo has begun the first-ever trial to test the effectiveness and safety of four experimental Ebola drugs, the first time scientists have directly compared such treatments, the World Health Organization said Monday. The U.N. health agency described the multi-drug trial as "a...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 2:17 am
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8:20 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a...
Read More

Pages